Amarin Corp Plc (AMRN)

[sts66]

Unfortunately, AMRN will either have booming US sales based on R-IT results by the time they get China marketing approval, or will have gone out of business - estimated time to gain approval in China is around 2019 - Edingpharm must run new clinical trials using Chinese subjects, can't use prior data AMRN already has - same rule applies in Taiwan, where ARNA is trying to gain approval for Belviq.